0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Butylscopolamine Bromide Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-29C5764
Home | Market Reports | Health | Health Conditions | Pain Management
Global Butylscopolamine Bromide Market Insights and Forecast to 2028

Global Butylscopolamine Bromide Market Insights and Forecast to 2028

Code: QYRE-Auto-29C5764
Report
May 2022
106 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.
Market Analysis and Insights: Global Butylscopolamine Bromide Market

The global Butylscopolamine Bromide market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Tablets accounting for % of the Butylscopolamine Bromide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Stomach segment is altered to an % CAGR throughout this forecast period.
China Butylscopolamine Bromide market size is valued at US$ million in 2021, while the North America and Europe Butylscopolamine Bromide are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Butylscopolamine Bromide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Butylscopolamine Bromide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Butylscopolamine Bromide market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Butylscopolamine Bromide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Butylscopolamine Bromide market.
Global Butylscopolamine Bromide Scope and Market Size
Butylscopolamine Bromide market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Butylscopolamine Bromide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Tablets
Capsule
Intramuscular Injection
Intravenous Or Drip
Suppositories
Other

Segment by Application

Stomach
Gas Barium Hypography
Abdominal CT Scan
Gastrointestinal Spasm
Biliary Colic
Renal Colic
Gastrointestinal Hypermotility
Other

BY COMPANY

Sanofi
Boehringer Ingelheim
Sandoz (Novartis)
Boehringer Ingelheim Pharma GmbH & Co. KG
XI AN TIANXINGJIAN PHARMCHEM
Linnea
Alkaloida
Chengdu Tiantaishan Pharmaceutical
Jiangsu Ange Pharmaceutical
Chengdu First Pharmaceutical
Beijing Zizhu Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Wanbangde Pharmaceutical Group
Shandong Yijian Pharmaceutical

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Butylscopolamine Bromide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Intramuscular Injection
1.2.5 Intravenous Or Drip
1.2.6 Suppositories
1.2.7 Other
1.3 Market by Application
1.3.1 Global Butylscopolamine Bromide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Stomach
1.3.3 Gas Barium Hypography
1.3.4 Abdominal CT Scan
1.3.5 Gastrointestinal Spasm
1.3.6 Biliary Colic
1.3.7 Renal Colic
1.3.8 Gastrointestinal Hypermotility
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Butylscopolamine Bromide Market Perspective (2017-2028)
2.2 Butylscopolamine Bromide Growth Trends by Region
2.2.1 Butylscopolamine Bromide Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Butylscopolamine Bromide Historic Market Size by Region (2017-2022)
2.2.3 Butylscopolamine Bromide Forecasted Market Size by Region (2023-2028)
2.3 Butylscopolamine Bromide Market Dynamics
2.3.1 Butylscopolamine Bromide Industry Trends
2.3.2 Butylscopolamine Bromide Market Drivers
2.3.3 Butylscopolamine Bromide Market Challenges
2.3.4 Butylscopolamine Bromide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Butylscopolamine Bromide Players by Revenue
3.1.1 Global Top Butylscopolamine Bromide Players by Revenue (2017-2022)
3.1.2 Global Butylscopolamine Bromide Revenue Market Share by Players (2017-2022)
3.2 Global Butylscopolamine Bromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Butylscopolamine Bromide Revenue
3.4 Global Butylscopolamine Bromide Market Concentration Ratio
3.4.1 Global Butylscopolamine Bromide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Butylscopolamine Bromide Revenue in 2021
3.5 Butylscopolamine Bromide Key Players Head office and Area Served
3.6 Key Players Butylscopolamine Bromide Product Solution and Service
3.7 Date of Enter into Butylscopolamine Bromide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Butylscopolamine Bromide Breakdown Data by Type
4.1 Global Butylscopolamine Bromide Historic Market Size by Type (2017-2022)
4.2 Global Butylscopolamine Bromide Forecasted Market Size by Type (2023-2028)
5 Butylscopolamine Bromide Breakdown Data by Application
5.1 Global Butylscopolamine Bromide Historic Market Size by Application (2017-2022)
5.2 Global Butylscopolamine Bromide Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Butylscopolamine Bromide Market Size (2017-2028)
6.2 North America Butylscopolamine Bromide Market Size by Type
6.2.1 North America Butylscopolamine Bromide Market Size by Type (2017-2022)
6.2.2 North America Butylscopolamine Bromide Market Size by Type (2023-2028)
6.2.3 North America Butylscopolamine Bromide Market Share by Type (2017-2028)
6.3 North America Butylscopolamine Bromide Market Size by Application
6.3.1 North America Butylscopolamine Bromide Market Size by Application (2017-2022)
6.3.2 North America Butylscopolamine Bromide Market Size by Application (2023-2028)
6.3.3 North America Butylscopolamine Bromide Market Share by Application (2017-2028)
6.4 North America Butylscopolamine Bromide Market Size by Country
6.4.1 North America Butylscopolamine Bromide Market Size by Country (2017-2022)
6.4.2 North America Butylscopolamine Bromide Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Butylscopolamine Bromide Market Size (2017-2028)
7.2 Europe Butylscopolamine Bromide Market Size by Type
7.2.1 Europe Butylscopolamine Bromide Market Size by Type (2017-2022)
7.2.2 Europe Butylscopolamine Bromide Market Size by Type (2023-2028)
7.2.3 Europe Butylscopolamine Bromide Market Share by Type (2017-2028)
7.3 Europe Butylscopolamine Bromide Market Size by Application
7.3.1 Europe Butylscopolamine Bromide Market Size by Application (2017-2022)
7.3.2 Europe Butylscopolamine Bromide Market Size by Application (2023-2028)
7.3.3 Europe Butylscopolamine Bromide Market Share by Application (2017-2028)
7.4 Europe Butylscopolamine Bromide Market Size by Country
7.4.1 Europe Butylscopolamine Bromide Market Size by Country (2017-2022)
7.4.2 Europe Butylscopolamine Bromide Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Butylscopolamine Bromide Market Size (2017-2028)
8.2 Asia-Pacific Butylscopolamine Bromide Market Size by Type
8.2.1 Asia-Pacific Butylscopolamine Bromide Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Butylscopolamine Bromide Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Butylscopolamine Bromide Market Share by Type (2017-2028)
8.3 Asia-Pacific Butylscopolamine Bromide Market Size by Application
8.3.1 Asia-Pacific Butylscopolamine Bromide Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Butylscopolamine Bromide Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Butylscopolamine Bromide Market Share by Application (2017-2028)
8.4 Asia-Pacific Butylscopolamine Bromide Market Size by Region
8.4.1 Asia-Pacific Butylscopolamine Bromide Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Butylscopolamine Bromide Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Butylscopolamine Bromide Market Size (2017-2028)
9.2 Latin America Butylscopolamine Bromide Market Size by Type
9.2.1 Latin America Butylscopolamine Bromide Market Size by Type (2017-2022)
9.2.2 Latin America Butylscopolamine Bromide Market Size by Type (2023-2028)
9.2.3 Latin America Butylscopolamine Bromide Market Share by Type (2017-2028)
9.3 Latin America Butylscopolamine Bromide Market Size by Application
9.3.1 Latin America Butylscopolamine Bromide Market Size by Application (2017-2022)
9.3.2 Latin America Butylscopolamine Bromide Market Size by Application (2023-2028)
9.3.3 Latin America Butylscopolamine Bromide Market Share by Application (2017-2028)
9.4 Latin America Butylscopolamine Bromide Market Size by Country
9.4.1 Latin America Butylscopolamine Bromide Market Size by Country (2017-2022)
9.4.2 Latin America Butylscopolamine Bromide Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Butylscopolamine Bromide Market Size (2017-2028)
10.2 Middle East & Africa Butylscopolamine Bromide Market Size by Type
10.2.1 Middle East & Africa Butylscopolamine Bromide Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Butylscopolamine Bromide Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Butylscopolamine Bromide Market Share by Type (2017-2028)
10.3 Middle East & Africa Butylscopolamine Bromide Market Size by Application
10.3.1 Middle East & Africa Butylscopolamine Bromide Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Butylscopolamine Bromide Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Butylscopolamine Bromide Market Share by Application (2017-2028)
10.4 Middle East & Africa Butylscopolamine Bromide Market Size by Country
10.4.1 Middle East & Africa Butylscopolamine Bromide Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Butylscopolamine Bromide Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Butylscopolamine Bromide Introduction
11.1.4 Sanofi Revenue in Butylscopolamine Bromide Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Butylscopolamine Bromide Introduction
11.2.4 Boehringer Ingelheim Revenue in Butylscopolamine Bromide Business (2017-2022)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Details
11.3.2 Sandoz (Novartis) Business Overview
11.3.3 Sandoz (Novartis) Butylscopolamine Bromide Introduction
11.3.4 Sandoz (Novartis) Revenue in Butylscopolamine Bromide Business (2017-2022)
11.3.5 Sandoz (Novartis) Recent Developments
11.4 Boehringer Ingelheim Pharma GmbH & Co. KG
11.4.1 Boehringer Ingelheim Pharma GmbH & Co. KG Company Details
11.4.2 Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
11.4.3 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Introduction
11.4.4 Boehringer Ingelheim Pharma GmbH & Co. KG Revenue in Butylscopolamine Bromide Business (2017-2022)
11.4.5 Boehringer Ingelheim Pharma GmbH & Co. KG Recent Developments
11.5 XI AN TIANXINGJIAN PHARMCHEM
11.5.1 XI AN TIANXINGJIAN PHARMCHEM Company Details
11.5.2 XI AN TIANXINGJIAN PHARMCHEM Business Overview
11.5.3 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Introduction
11.5.4 XI AN TIANXINGJIAN PHARMCHEM Revenue in Butylscopolamine Bromide Business (2017-2022)
11.5.5 XI AN TIANXINGJIAN PHARMCHEM Recent Developments
11.6 Linnea
11.6.1 Linnea Company Details
11.6.2 Linnea Business Overview
11.6.3 Linnea Butylscopolamine Bromide Introduction
11.6.4 Linnea Revenue in Butylscopolamine Bromide Business (2017-2022)
11.6.5 Linnea Recent Developments
11.7 Alkaloida
11.7.1 Alkaloida Company Details
11.7.2 Alkaloida Business Overview
11.7.3 Alkaloida Butylscopolamine Bromide Introduction
11.7.4 Alkaloida Revenue in Butylscopolamine Bromide Business (2017-2022)
11.7.5 Alkaloida Recent Developments
11.8 Chengdu Tiantaishan Pharmaceutical
11.8.1 Chengdu Tiantaishan Pharmaceutical Company Details
11.8.2 Chengdu Tiantaishan Pharmaceutical Business Overview
11.8.3 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Introduction
11.8.4 Chengdu Tiantaishan Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022)
11.8.5 Chengdu Tiantaishan Pharmaceutical Recent Developments
11.9 Jiangsu Ange Pharmaceutical
11.9.1 Jiangsu Ange Pharmaceutical Company Details
11.9.2 Jiangsu Ange Pharmaceutical Business Overview
11.9.3 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Introduction
11.9.4 Jiangsu Ange Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022)
11.9.5 Jiangsu Ange Pharmaceutical Recent Developments
11.10 Chengdu First Pharmaceutical
11.10.1 Chengdu First Pharmaceutical Company Details
11.10.2 Chengdu First Pharmaceutical Business Overview
11.10.3 Chengdu First Pharmaceutical Butylscopolamine Bromide Introduction
11.10.4 Chengdu First Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022)
11.10.5 Chengdu First Pharmaceutical Recent Developments
11.11 Beijing Zizhu Pharmaceutical
11.11.1 Beijing Zizhu Pharmaceutical Company Details
11.11.2 Beijing Zizhu Pharmaceutical Business Overview
11.11.3 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Introduction
11.11.4 Beijing Zizhu Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022)
11.11.5 Beijing Zizhu Pharmaceutical Recent Developments
11.12 Guangdong Zhongsheng Pharmaceutical
11.12.1 Guangdong Zhongsheng Pharmaceutical Company Details
11.12.2 Guangdong Zhongsheng Pharmaceutical Business Overview
11.12.3 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Introduction
11.12.4 Guangdong Zhongsheng Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022)
11.12.5 Guangdong Zhongsheng Pharmaceutical Recent Developments
11.13 Wanbangde Pharmaceutical Group
11.13.1 Wanbangde Pharmaceutical Group Company Details
11.13.2 Wanbangde Pharmaceutical Group Business Overview
11.13.3 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Introduction
11.13.4 Wanbangde Pharmaceutical Group Revenue in Butylscopolamine Bromide Business (2017-2022)
11.13.5 Wanbangde Pharmaceutical Group Recent Developments
11.14 Shandong Yijian Pharmaceutical
11.14.1 Shandong Yijian Pharmaceutical Company Details
11.14.2 Shandong Yijian Pharmaceutical Business Overview
11.14.3 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Introduction
11.14.4 Shandong Yijian Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022)
11.14.5 Shandong Yijian Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Butylscopolamine Bromide Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Tablets
    Table 3. Key Players of Capsule
    Table 4. Key Players of Intramuscular Injection
    Table 5. Key Players of Intravenous Or Drip
    Table 6. Key Players of Suppositories
    Table 7. Key Players of Other
    Table 8. Global Butylscopolamine Bromide Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Butylscopolamine Bromide Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Butylscopolamine Bromide Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Butylscopolamine Bromide Market Share by Region (2017-2022)
    Table 12. Global Butylscopolamine Bromide Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Butylscopolamine Bromide Market Share by Region (2023-2028)
    Table 14. Butylscopolamine Bromide Market Trends
    Table 15. Butylscopolamine Bromide Market Drivers
    Table 16. Butylscopolamine Bromide Market Challenges
    Table 17. Butylscopolamine Bromide Market Restraints
    Table 18. Global Butylscopolamine Bromide Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Butylscopolamine Bromide Revenue Share by Players (2017-2022)
    Table 20. Global Top Butylscopolamine Bromide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butylscopolamine Bromide as of 2021)
    Table 21. Ranking of Global Top Butylscopolamine Bromide Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Butylscopolamine Bromide Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Butylscopolamine Bromide Product Solution and Service
    Table 25. Date of Enter into Butylscopolamine Bromide Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Butylscopolamine Bromide Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Butylscopolamine Bromide Revenue Market Share by Type (2017-2022)
    Table 29. Global Butylscopolamine Bromide Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Butylscopolamine Bromide Revenue Market Share by Type (2023-2028)
    Table 31. Global Butylscopolamine Bromide Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Butylscopolamine Bromide Revenue Share by Application (2017-2022)
    Table 33. Global Butylscopolamine Bromide Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Butylscopolamine Bromide Revenue Share by Application (2023-2028)
    Table 35. North America Butylscopolamine Bromide Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Butylscopolamine Bromide Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Butylscopolamine Bromide Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Butylscopolamine Bromide Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Butylscopolamine Bromide Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Butylscopolamine Bromide Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Butylscopolamine Bromide Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Butylscopolamine Bromide Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Butylscopolamine Bromide Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Butylscopolamine Bromide Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Butylscopolamine Bromide Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Butylscopolamine Bromide Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Butylscopolamine Bromide Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Butylscopolamine Bromide Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Butylscopolamine Bromide Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Butylscopolamine Bromide Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Butylscopolamine Bromide Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Butylscopolamine Bromide Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Butylscopolamine Bromide Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Butylscopolamine Bromide Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Butylscopolamine Bromide Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Butylscopolamine Bromide Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Butylscopolamine Bromide Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Butylscopolamine Bromide Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Butylscopolamine Bromide Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Butylscopolamine Bromide Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Butylscopolamine Bromide Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Butylscopolamine Bromide Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Butylscopolamine Bromide Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Butylscopolamine Bromide Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Sanofi Company Details
    Table 66. Sanofi Business Overview
    Table 67. Sanofi Butylscopolamine Bromide Product
    Table 68. Sanofi Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 69. Sanofi Recent Developments
    Table 70. Boehringer Ingelheim Company Details
    Table 71. Boehringer Ingelheim Business Overview
    Table 72. Boehringer Ingelheim Butylscopolamine Bromide Product
    Table 73. Boehringer Ingelheim Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 74. Boehringer Ingelheim Recent Developments
    Table 75. Sandoz (Novartis) Company Details
    Table 76. Sandoz (Novartis) Business Overview
    Table 77. Sandoz (Novartis) Butylscopolamine Bromide Product
    Table 78. Sandoz (Novartis) Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 79. Sandoz (Novartis) Recent Developments
    Table 80. Boehringer Ingelheim Pharma GmbH & Co. KG Company Details
    Table 81. Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
    Table 82. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product
    Table 83. Boehringer Ingelheim Pharma GmbH & Co. KG Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 84. Boehringer Ingelheim Pharma GmbH & Co. KG Recent Developments
    Table 85. XI AN TIANXINGJIAN PHARMCHEM Company Details
    Table 86. XI AN TIANXINGJIAN PHARMCHEM Business Overview
    Table 87. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product
    Table 88. XI AN TIANXINGJIAN PHARMCHEM Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 89. XI AN TIANXINGJIAN PHARMCHEM Recent Developments
    Table 90. Linnea Company Details
    Table 91. Linnea Business Overview
    Table 92. Linnea Butylscopolamine Bromide Product
    Table 93. Linnea Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 94. Linnea Recent Developments
    Table 95. Alkaloida Company Details
    Table 96. Alkaloida Business Overview
    Table 97. Alkaloida Butylscopolamine Bromide Product
    Table 98. Alkaloida Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 99. Alkaloida Recent Developments
    Table 100. Chengdu Tiantaishan Pharmaceutical Company Details
    Table 101. Chengdu Tiantaishan Pharmaceutical Business Overview
    Table 102. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Product
    Table 103. Chengdu Tiantaishan Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 104. Chengdu Tiantaishan Pharmaceutical Recent Developments
    Table 105. Jiangsu Ange Pharmaceutical Company Details
    Table 106. Jiangsu Ange Pharmaceutical Business Overview
    Table 107. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product
    Table 108. Jiangsu Ange Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 109. Jiangsu Ange Pharmaceutical Recent Developments
    Table 110. Chengdu First Pharmaceutical Company Details
    Table 111. Chengdu First Pharmaceutical Business Overview
    Table 112. Chengdu First Pharmaceutical Butylscopolamine Bromide Product
    Table 113. Chengdu First Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 114. Chengdu First Pharmaceutical Recent Developments
    Table 115. Beijing Zizhu Pharmaceutical Company Details
    Table 116. Beijing Zizhu Pharmaceutical Business Overview
    Table 117. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product
    Table 118. Beijing Zizhu Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 119. Beijing Zizhu Pharmaceutical Recent Developments
    Table 120. Guangdong Zhongsheng Pharmaceutical Company Details
    Table 121. Guangdong Zhongsheng Pharmaceutical Business Overview
    Table 122. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product
    Table 123. Guangdong Zhongsheng Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 124. Guangdong Zhongsheng Pharmaceutical Recent Developments
    Table 125. Wanbangde Pharmaceutical Group Company Details
    Table 126. Wanbangde Pharmaceutical Group Business Overview
    Table 127. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product
    Table 128. Wanbangde Pharmaceutical Group Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 129. Wanbangde Pharmaceutical Group Recent Developments
    Table 130. Shandong Yijian Pharmaceutical Company Details
    Table 131. Shandong Yijian Pharmaceutical Business Overview
    Table 132. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product
    Table 133. Shandong Yijian Pharmaceutical Revenue in Butylscopolamine Bromide Business (2017-2022) & (US$ Million)
    Table 134. Shandong Yijian Pharmaceutical Recent Developments
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Butylscopolamine Bromide Market Share by Type: 2021 VS 2028
    Figure 2. Tablets Features
    Figure 3. Capsule Features
    Figure 4. Intramuscular Injection Features
    Figure 5. Intravenous Or Drip Features
    Figure 6. Suppositories Features
    Figure 7. Other Features
    Figure 8. Global Butylscopolamine Bromide Market Share by Application: 2021 VS 2028
    Figure 9. Stomach Case Studies
    Figure 10. Gas Barium Hypography Case Studies
    Figure 11. Abdominal CT Scan Case Studies
    Figure 12. Gastrointestinal Spasm Case Studies
    Figure 13. Biliary Colic Case Studies
    Figure 14. Renal Colic Case Studies
    Figure 15. Gastrointestinal Hypermotility Case Studies
    Figure 16. Other Case Studies
    Figure 17. Butylscopolamine Bromide Report Years Considered
    Figure 18. Global Butylscopolamine Bromide Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 19. Global Butylscopolamine Bromide Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Butylscopolamine Bromide Market Share by Region: 2021 VS 2028
    Figure 21. Global Butylscopolamine Bromide Market Share by Players in 2021
    Figure 22. Global Top Butylscopolamine Bromide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butylscopolamine Bromide as of 2021)
    Figure 23. The Top 10 and 5 Players Market Share by Butylscopolamine Bromide Revenue in 2021
    Figure 24. North America Butylscopolamine Bromide Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. North America Butylscopolamine Bromide Market Size Market Share by Type (2017-2028)
    Figure 26. North America Butylscopolamine Bromide Market Size Market Share by Application (2017-2028)
    Figure 27. North America Butylscopolamine Bromide Market Size Share by Country (2017-2028)
    Figure 28. United States Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Canada Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Europe Butylscopolamine Bromide Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Europe Butylscopolamine Bromide Market Size Market Share by Type (2017-2028)
    Figure 32. Europe Butylscopolamine Bromide Market Size Market Share by Application (2017-2028)
    Figure 33. Europe Butylscopolamine Bromide Market Size Share by Country (2017-2028)
    Figure 34. Germany Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. France Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. U.K. Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Italy Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Russia Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Nordic Countries Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Butylscopolamine Bromide Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Asia Pacific Butylscopolamine Bromide Market Size Market Share by Type (2017-2028)
    Figure 42. Asia Pacific Butylscopolamine Bromide Market Size Market Share by Application (2017-2028)
    Figure 43. Asia Pacific Butylscopolamine Bromide Market Size Share by Region (2017-2028)
    Figure 44. China Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Japan Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. South Korea Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Southeast Asia Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. India Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Australia Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 50. Latin America Butylscopolamine Bromide Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Latin America Butylscopolamine Bromide Market Size Market Share by Type (2017-2028)
    Figure 52. Latin America Butylscopolamine Bromide Market Size Market Share by Application (2017-2028)
    Figure 53. Latin America Butylscopolamine Bromide Market Size Share by Country (2017-2028)
    Figure 54. Mexico Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Brazil Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Middle East & Africa Butylscopolamine Bromide Market Size YoY (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Butylscopolamine Bromide Market Size Market Share by Type (2017-2028)
    Figure 58. Middle East and Africa Butylscopolamine Bromide Market Size Market Share by Application (2017-2028)
    Figure 59. Middle East and Africa Butylscopolamine Bromide Market Size Share by Country (2017-2028)
    Figure 60. Turkey Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. Saudi Arabia Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. UAE Butylscopolamine Bromide Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 63. Sanofi Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 64. Boehringer Ingelheim Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 65. Sandoz (Novartis) Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 66. Boehringer Ingelheim Pharma GmbH & Co. KG Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 67. XI AN TIANXINGJIAN PHARMCHEM Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 68. Linnea Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 69. Alkaloida Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 70. Chengdu Tiantaishan Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 71. Jiangsu Ange Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 72. Chengdu First Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 73. Beijing Zizhu Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 74. Guangdong Zhongsheng Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 75. Wanbangde Pharmaceutical Group Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 76. Shandong Yijian Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Nimesulide Market Insights and Forecast to 2028
Global Nimesulide Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-32B7766
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Ketorolac Market Insights and Forecast to 2028
Global Ketorolac Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-36L5761
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Indometacin Indomethacin Market Insights and Forecast to 2028
Global Indometacin (Indomethacin) Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-1V6138
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Butylscopolamine Bromide Market Insights and Forecast to 2028
Global Butylscopolamine Bromide Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-29C5764
Tue May 03 00:00:00 UTC 2022

Add to Cart